Dulaglutide improves glucocorticoid-induced hyperglycemia in inpatient care and reduces dose and injection frequency of insulin

BACKGROUND: Glucocorticoid (GC)-induced hyperglycemia is characterized by elevated postprandial blood glucose, which commonly requires multiple insulin injections. We investigated whether a long-acting glucagon-like peptide-1 receptor agonist, dulaglutide (Dula), safely improved GC-induced hyperglyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchinuma, Hiroyuki, Ichijo, Masashi, Harima, Noriyuki, Tsuchiya, Kyoichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203793/
https://www.ncbi.nlm.nih.gov/pubmed/32381085
http://dx.doi.org/10.1186/s12902-020-0542-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203793/
https://www.ncbi.nlm.nih.gov/pubmed/32381085
http://dx.doi.org/10.1186/s12902-020-0542-5

Ejemplares similares